US11946911B2 - Analysis system and method for rapidly detecting vitamin d in an oil or fat, or a biological sample - Google Patents
Analysis system and method for rapidly detecting vitamin d in an oil or fat, or a biological sample Download PDFInfo
- Publication number
- US11946911B2 US11946911B2 US17/049,249 US201917049249A US11946911B2 US 11946911 B2 US11946911 B2 US 11946911B2 US 201917049249 A US201917049249 A US 201917049249A US 11946911 B2 US11946911 B2 US 11946911B2
- Authority
- US
- United States
- Prior art keywords
- reverse phase
- liquid chromatography
- supercritical
- phase liquid
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 229940046008 vitamin d Drugs 0.000 title claims abstract description 96
- 238000000034 method Methods 0.000 title claims abstract description 53
- 238000004458 analytical method Methods 0.000 title claims abstract description 38
- 239000012472 biological sample Substances 0.000 title claims abstract description 17
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims abstract description 150
- 238000004808 supercritical fluid chromatography Methods 0.000 claims abstract description 111
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 96
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 95
- 239000011710 vitamin D Substances 0.000 claims abstract description 95
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 95
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 95
- 239000003607 modifier Substances 0.000 claims abstract description 53
- 239000000523 sample Substances 0.000 claims abstract description 49
- 238000001514 detection method Methods 0.000 claims abstract description 24
- 238000000148 multi-dimensional chromatography Methods 0.000 claims abstract description 24
- 238000000926 separation method Methods 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims description 49
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 47
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 27
- 239000007864 aqueous solution Substances 0.000 claims description 19
- 230000005526 G1 to G0 transition Effects 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 239000001569 carbon dioxide Substances 0.000 claims description 17
- 239000000741 silica gel Substances 0.000 claims description 17
- 229910002027 silica gel Inorganic materials 0.000 claims description 17
- 238000004587 chromatography analysis Methods 0.000 claims description 15
- 150000002825 nitriles Chemical class 0.000 claims description 14
- 239000003495 polar organic solvent Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 9
- 235000004252 protein component Nutrition 0.000 claims description 7
- 125000001165 hydrophobic group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 125000003158 alcohol group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 112
- 239000012071 phase Substances 0.000 description 72
- 230000014759 maintenance of location Effects 0.000 description 28
- 239000011647 vitamin D3 Substances 0.000 description 23
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 23
- 239000003925 fat Substances 0.000 description 21
- 239000003921 oil Substances 0.000 description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- 150000002009 diols Chemical group 0.000 description 15
- 239000012530 fluid Substances 0.000 description 12
- 239000011653 vitamin D2 Substances 0.000 description 12
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000012488 sample solution Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000032258 transport Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000005191 phase separation Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- -1 and is preferably Chemical compound 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 238000004811 liquid chromatography Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000003953 normal phase liquid chromatography Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000004885 tandem mass spectrometry Methods 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 235000019195 vitamin supplement Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 238000004780 2D liquid chromatography Methods 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002552 multiple reaction monitoring Methods 0.000 description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- XQFJZHAVTPYDIQ-LETJEVNCSA-N (1s)-3-[(e)-2-[(1r,3ar,7ar)-1-[(e,2r,5r)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol Chemical compound C=1([C@@H]2CC[C@@H]([C@]2(CCC=1)C)[C@H](C)/C=C/[C@H](C)C(C)C)\C=C\C1=C(C)CC[C@H](O)C1 XQFJZHAVTPYDIQ-LETJEVNCSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 1
- 102220594896 Vasopressin-neurophysin 2-copeptin_M20A_mutation Human genes 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000014105 formulated food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- DNVPQKQSNYMLRS-YAPGYIAOSA-N lumisterol Chemical compound C1[C@@H](O)CC[C@@]2(C)[C@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-YAPGYIAOSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000020610 powder formula Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- YUGCAAVRZWBXEQ-WHTXLNIXSA-N previtamin D3 Chemical compound C=1([C@@H]2CC[C@@H]([C@]2(CCC=1)C)[C@H](C)CCCC(C)C)\C=C/C1=C(C)CC[C@H](O)C1 YUGCAAVRZWBXEQ-WHTXLNIXSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- BUNBVCKYYMRTNS-UHFFFAOYSA-N tachysterol Natural products C=1CCC2(C)C(C(C)CCC(C)C(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 BUNBVCKYYMRTNS-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/461—Flow patterns using more than one column with serial coupling of separation columns
- G01N30/463—Flow patterns using more than one column with serial coupling of separation columns for multidimensional chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/065—Preparation using different phases to separate parts of sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/89—Inverse chromatography
Definitions
- the present invention relates to separation of highly lipophilic components from an oil or fat, or a biological sample, in particular, relates to an analysis system that is applied to separation of vitamin components, and belongs to the field of separation of natural substances.
- Vitamin D 2 also referred to as “ergocalciferol”
- vitamin D 3 (“cholecalciferol”) are lipophilic vitamins, and play a very important role in the metabolism of calcium. Vitamin D affects another metabolism pathway. Lack of vitamin D causes major diseases such as rickets and osteoporosis.
- Vitamin D supplements are generally used for therapy or prevention of vitamin deficiency.
- vitamin D is added to prepared milk powder for infants. Incidentally, excessive intake of vitamin D may cause a risk. For this reason, appropriate use of vitamin D for vitamin supplements and formulated foods for infants plays a very important role in the medical care and the health.
- a method of measuring vitamin D generally includes extracting vitamin D from an oil or fat, or a fatty substrate with a solvent, washing the extracted vitamin D by normal phase liquid chromatography (NPLC), and then performing separation and detection by a reverse phase liquid chromatography column (RPLC).
- NPLC normal phase liquid chromatography
- RPLC reverse phase liquid chromatography column
- Non Patent Literature 1 discloses a method of simultaneously measuring vitamin A, vitamin D 3 , and vitamin E in formulated nutrient products for infants and adults, on the basis of reverse phase chromatography for one-dimensional separation and two-dimensional separation, by an online two-dimensional liquid chromatography method. The method involves saponifying and extracting a sample and then directly injecting the sample to perform analysis, and thus enables a quantitative analysis of respective vitamins in the sample at online even in one injection.
- Non Patent Literature 2 relates to a high-speed and high-sensitivity analysis method that employs UPLC-MS/MS and enables simultaneous measurement of lipophilic vitamin A, D 2 , D 3 , and ⁇ -tocopherol in prepared milk powder for infants.
- the method still requires treatment of the detected sample with an alkaline inorganic substance and extraction with an organic solvent.
- a chromatography method which purifies an oil or fat, or a fatty sample with a normal phase liquid at online is still required. Then, it is possible to analyze a fatty eluate separated at a low level by reverse phase liquid chromatography to provide better resolution.
- two types of different mobile phases do not match to each other. Thus, it is difficult to establish a column switching system including both normal phase chromatography and reverse phase liquid chromatography at the same time.
- Patent Literature 1 discloses a method of separating vitamin D 3 or previtamin D 3 from a mixture with other components such as dehydrocholesterol, tachysterol, and lumisterol by column chromatography using supercritical carbon dioxide as a mobile phase. However, this method relates to only separation or purification after synthesis of a vitamin D product.
- the present invention provides a method and analysis system that rapidly analyze highly lipophilic components, in particular, vitamin D in an oil or fat, or a biological sample by using a multidimensional chromatography system.
- the present invention employs reverse phase liquid chromatography and a supercritical chromatograph in combination, simply and rapidly separates highly lipophilic components, in particular, vitamin D, contained in an oil or fat, or a biological sample, and further detects and analyzes the separated vitamin D by using a detection apparatus.
- the method and analysis system of the present invention allow convenient and rapid switching between different chromatography columns, thus allowing rapid and accurate detection of highly lipophilic components.
- the present invention solves the above problems by the following embodiments.
- the present invention first provides:
- the present invention further provides the following embodiments.
- the present invention can provide the following advantageous effects by the above technological embodiments.
- the multidimensional chromatography system provided by the present invention can achieve direct switching between different types of chromatography columns, that is, between a supercritical chromatography column and a reverse phase liquid chromatography column.
- the multidimensional chromatography provided by the present invention can prevent a defect that there is no compatibility in a mobile phase when different types of columns are normally used in combination.
- the method or analysis system provided by the present invention allows rapid and accurate analysis and detection of highly lipophilic components, in particular, these components, for example, vitamin D in an oil or fat, or a biological sample.
- the method or analysis system provided by the present invention especially allows operation with high-level automation, thus remarkably improving analysis efficiency and reducing analysis cost.
- detecting highly lipophilic components, in particular, vitamin D components by the method of the present invention provides a detection result exhibiting a favorable linear correlation coefficient, and also provides a favorable reproducibility and a high recovery.
- FIGS. 1 A to 1 C are flow charts of a detection process of vitamin D according to an embodiment of the present invention.
- FIG. 2 A to 2 C show the effect of the used amount of modifier relative to CO 2 on the retention behavior of different columns in an SFC process.
- FIG. 3 shows the effect of different contents of methanol in a diol group column on the retention behavior.
- FIG. 4 shows the effect of different contents of methanol in a C18 column on the retention behavior.
- FIG. 5 shows the result of a detection analysis on a standard sample.
- FIG. 6 shows the result of a detection analysis on a standard sample.
- FIG. 7 shows the analysis of oily droplet vitamin D 3 .
- the first embodiment of the present invention provides a method that can rapidly detects highly lipophilic components, in particular, highly lipophilic components in an oil or fat sample, or a biological sample.
- highly lipophilic components in particular, highly lipophilic components in an oil or fat sample, or a biological sample.
- vitamin D serving as a representative of the lipophilic components will be described as follows.
- An object to be analyzed may be substances containing various highly lipophilic components, in particular, nutritional supplementary foods or nutrients containing vitamin D, or may be prepared milk powder or foods for infants.
- these substances containing vitamin D may be in the form of solid, or may be in the form of liquid or paste.
- these samples do not have to be subjected to pretreatment as necessary.
- a means for pretreatment is not particularly limited as long as the content of vitamin D in the sample to be analyzed is not impaired.
- a fine powder can be obtained by using a means such as drying and crushing.
- a pretreatment means such as saponification, and enzymatic degradation can be used for milk powder or rice powder, for example.
- the sample to be analyzed is directly subjected to extraction treatment for a part of oil or fat components with an organic solvent, thereby extracting components such as vitamin D in the sample into the organic solvent.
- the sample that has been pretreated as necessary is dissolved or diluted with an organic solvent, thus preparing a sample solution to be analyzed.
- the organic solvent can be selected from a hydrocarbon solvent, a ketone solvent, an ether solvent and other similar substances.
- a hydrocarbon solvent such as n-hexane can be used.
- a solution of a sample to be analyzed that has been already dissolved can be injected into a detection apparatus by an autosampler.
- protein components in the sample can be removed by, for example, chromatography before the sample is subjected to detection.
- protein components in the sample are removed by using a pretreatment column in advance, and then vitamin D components are separated and detected in the sample.
- the present invention allows detection for a biological sample containing vitamin D, such as blood.
- the multidimensional chromatography system of the present invention provides a role of preliminary washing and separating a sample solution to be analyzed.
- the multidimensional chromatography system includes a supercritical chromatography part and a reverse phase liquid chromatography part.
- the supercritical fluid chromatography is a chromatography process that uses a supercritical fluid as a mobile phase and performs separation and analysis of components due to ability of the mobile phase to work as a solvent.
- the supercritical fluid chromatography has characteristics of both gas chromatography and liquid chromatography.
- the supercritical fluid chromatography enables analysis of a low volatile sample with a high boiling point, which is not suitable for gas chromatography, and provides more rapid analysis speed and optimal conditions than high performance liquid chromatography.
- a sample solution is preliminary washed by using a supercritical chromatography column. That is, nonpolar oil or fat components in the sample solution to be analyzed are removed.
- the supercritical chromatography column may be a packed column, or may be a capillary column.
- packed column supercritical fluid chromatography PCSFC is preferable.
- the stationary phase of the supercritical chromatography column is selected from a silica gel modified with a polar group.
- the polar group can be selected from a hydroxy group, an amino group, and a cyano group.
- a hydroxy group is preferably used as a modification group in consideration of the need to secure appropriate retention time of vitamin D.
- a diol group silica gel which is bonded by using 1,2-dihydroxypropyl functional group-containing organosilane, is preferably used as the stationary phase of supercritical chromatography column of the present invention.
- the stationary phase may be a porous spherical silica gel.
- a supercritical fluid which exhibits a state between gas and liquid of a substance under a condition of being equal to or more than the critical temperature and the critical pressure
- An appropriate supercritical fluid can be supercritical carbon dioxide or supercritical ethane.
- the supercritical mobile phase is selected from supercritical carbon dioxide.
- the working temperature and pressure are determined mainly depending on the selected supercritical mobile phase.
- the working temperature is 31° C. or more, and preferably 35° C. or more, and the working pressure is 7.3 MPa or more, and preferably 7.5 MPa or more.
- the working temperature is preferably 40 to 60° C.
- the working pressure is preferably 7.5 to 15 MPa.
- a modifier is used as a substance for adjusting the polarity of a supercritical carbon dioxide fluid.
- the modifier can be selected from alcohol and nitrile.
- various types of aliphatic alcohols such as methanol and isopropanol can be used among alcohols, and acetonitrile and the like can be used among nitriles.
- the used amount (relative flow rate) of the modifier can be usually 1% to 5% of the mobile phase.
- the amount of the modifier of the present invention is preferably 1.5% to 4%, more preferably 2% to 3%, and most preferably 2% to 2.5%.
- the purity of the modifier is 80% or more, preferably 90% or more, and more preferably 100%.
- the mobile phase and the modifier of the present invention can be supplied to the column by a liquid pump.
- the supercritical chromatography column of the present invention can be placed in an oven.
- the supercritical chromatography part may include a CO 2 supply pump independent from a detector and a pressure control unit (for example, a back-pressure control unit BPR).
- the pressure control unit is provided at an end of the supercritical chromatography part and is used for discharge of the mobile phase and waste liquid.
- the detector is not particularly limited.
- the detector is disposed before the back-pressure control unit, and can detect respective components eluted from the column.
- the detector can detect the outflow of vitamin D, thus enabling determination of the retention time of vitamin D in the sample solution.
- the detector may be a diode array detector.
- the supercritical chromatograph used for the present invention can be obtained from commercially available products, and may be, for example, “Nexera UC”, supercritical chromatography system available from Shimadzu Corporation.
- the sample solution is added to the supercritical chromatography part by an autosampler, and then the supercritical chromatograph is actuated.
- Weakly polar substances such as vitamin D in the sample remain in the column whereas nonpolar oils or fats are rapidly eluted from the column.
- the above switching can be performed by using a multi-way valve group.
- the multi-way valve group is not particularly limited, and various multi-way valves for injection can be used that are generally used in the field of liquid chromatography. In the present invention, use of a six-way valve group or a ten-way valve group is preferable, and use of a six-way valve group is more preferable.
- the different switching operation of the multi-way valve group can achieve different flow paths or different connection paths.
- Such a multi-way valve group is suitable for, in particular, connection and control between a plurality of types of apparatuses.
- Switching by a switching apparatus involves disconnecting the liquid outlet of the supercritical chromatography column from the detector and the pressure control apparatus, and simultaneously connecting the liquid outlet of the supercritical chromatography column to the liquid inlet of the reverse phase liquid chromatography via the multi-way valve group. Further, the end of the reverse phase liquid chromatography is connected to at least the pressure control unit via the multi-way valve group simultaneously.
- supply of the mobile phase to the supercritical chromatography column is stopped at the time of or before performing switching.
- Supply of the modifier is not stopped during the switching, and the supply rate of the modifier can be increased after completion of switching.
- the supply rate can be increased up to 0.5 to 1 mL/min.
- weakly polar substances which have been adsorbed to the supercritical chromatography column and contain vitamin D, are eluted by only the flow of the modifier, and can enter the reverse phase liquid chromatography part together with supercritical carbon dioxide left in the system through the multi-way valve.
- step S 21 That is, the components of the sample to be analyzed are separated by supercritical chromatography, and weakly polar substances containing vitamin D are transported to the reverse phase liquid chromatography part.
- step S 21 ′ That is, components of the sample are separated by supercritical chromatography, and weakly polar substances containing vitamin D are transported to a first reverse phase liquid chromatography column of the reverse phase liquid chromatography part.
- the reverse phase liquid chromatography part includes one or more reverse phase liquid chromatography columns. In some embodiments, these reverse phase liquid chromatography columns are placed in an oven at the time of use.
- the stationary phase of the reverse phase liquid chromatography column of the present invention may be a silica gel modified with a hydrophobic group.
- the above hydrophobic group may be various hydrocarbon groups such as a C8 group, a C18 group, and a phenyl group.
- a silica gel modified with a C18 group is used as the stationary phase.
- a polar organic solvent such as alcohol and nitrile, or an aqueous solution of such a polar organic solvent can be used.
- the alcohol various types of aliphatic alcohols such as methanol and isopropanol can be used.
- nitrile, acetonitrile and the like can be used.
- the mobile phase can be used as an aqueous solution.
- a methanol aqueous solution may be used.
- the content of the polar organic solvent in the mobile phase needs to be 60% or more, preferably 80% or more, and more preferably 90% or more from the viewpoint of reducing the retention time.
- the mobile phase of the reverse phase liquid chromatography is 90% or more methanol, or 100% methanol.
- the reverse phase liquid chromatography part can include only one column.
- the reverse phase liquid chromatography and the supercritical chromatography are connected in series after switching. At that time, the end of the reverse phase liquid chromatography is also switched or connected to the above pressure control unit.
- the above multi-way valve group also can achieve such a constitution of switching or connection.
- the weakly polar components adsorbed to the supercritical chromatography column continue to be eluted by the modifier after switching of the column.
- the flow rate of the modifier can be increased at that time from the viewpoint of improving the elution efficiency.
- these weakly polar components can be rapidly eluted from the supercritical chromatography column.
- these components enter the reverse phase liquid chromatography column together with the supercritical mobile phase remaining in the system.
- the end of the reverse phase liquid chromatography column has been already connected to the pressure control unit.
- the operation of the pressure control unit can discharge the supercritical mobile phase in the system to the outside of the system. Such a process does not affect the state of another mobile phase or components.
- Step S 22 is completed at this time. That is, in the reverse phase liquid chromatography, the mobile phase flowing out of the supercritical chromatogram is removed.
- a mobile phase is introduced into the reverse phase liquid chromatography column simultaneously with or after removal of the supercritical mobile phase by using the liquid pump of liquid chromatography.
- the mobile phase of the reverse phase liquid chromatography may be the same as or different from the modifier in the supercritical chromatography.
- both are the same.
- both are a methanol aqueous solution with a purity of 80% or more, a methanol aqueous solution with a purity of 90% or more, or a methanol with a purity of 100%.
- the supercritical mobile phase derived from the supercritical chromatography since the supercritical mobile phase derived from the supercritical chromatography has been removed, only the weakly polar components and the polar modifier which are to be separated in the reverse phase liquid chromatography, remain. In this case, a polar mobile phase can be directly introduced into the reverse phase liquid chromatography column. This allows solving of a problem with mismatch of the mobile phase at the time of switching between different types of columns.
- Step S 23 is completed at this time. That is, a mobile phase is further introduced in the above reverse phase liquid chromatography, and substances present in the reverse phase liquid chromatography are separated, thus obtaining the separated vitamin D components (step S 23 ).
- the vitamin D components herein include vitamin D 2 and vitamin D 3 components.
- step S 23 in particular, after the supercritical mobile phase derived from the supercritical chromatography column is removed by using the pressure control unit as described above, the reverse phase liquid chromatography is disconnected from the pressure control apparatus, and the reverse phase liquid chromatography is connected to a mass spectrometer by switching of the multi-way valve group. At this time, the separated vitamin D components can be detected and analyzed by using the mass spectrometer.
- the reverse phase liquid chromatography part can include two or more columns. In typical embodiments, the reverse phase liquid chromatography part can include two columns connected in series.
- the step S 21 ′ is the same as the above step S 21 .
- the components of the sample to be analyzed are separated by the supercritical chromatography to remove nonpolar oily substances, then supply of the supercritical mobile phase is stopped, and the modifier continues to be introduced. Switching between the columns via the multi-way valve group is performed by increasing the introduction flow rate of the modifier.
- the weakly polar components containing vitamin D adsorbed to the supercritical chromatography column can be transported to the first reverse phase liquid chromatography column.
- step S 22 ′ the end of the first reverse phase liquid chromatography column is first connected to the pressure control unit, and the supercritical mobile phase, which has been transported to the column, is discharged.
- the first reverse phase liquid chromatography is disconnected from the pressure control apparatus by switching of the multi-way valve group, and the pressure control apparatus is connected to a second reverse phase liquid chromatography.
- step S 23 ′ the liquid pump is actuated simultaneously with or after discharging of the supercritical mobile phase, and the polar mobile phase is transported to the first reverse phase liquid chromatography.
- the weakly polar components adsorbed to the first reverse phase liquid chromatography column is further eluted to the second reverse phase liquid chromatography column, thus separating the vitamin D components in the second reverse phase liquid chromatography column.
- the vitamin D separated in the second reverse phase liquid chromatography can be analyzed and detected by using the mass spectrometer connected to the column in series.
- the above first reverse phase liquid chromatography column and the second reverse phase liquid chromatography column may be the same or different. In a preferred embodiment of the present invention, both columns are different.
- the second reverse phase liquid chromatography column is longer than the first reverse phase liquid chromatography column.
- the first reverse phase liquid chromatography column can be considered to be a pretreatment column of the second reverse phase liquid chromatography column.
- the first reverse phase liquid chromatography column plays a role of collecting the weakly polar substances mainly containing vitamin D and removing the supercritical mobile phase.
- FIGS. 1 A to 1 C a preferred embodiment of the present invention will be described with reference to FIGS. 1 A to 1 C .
- a vitamin D supplement for infants was analyzed by the method of the present invention. An appropriate amount of the oily sample was taken, and the sample was dissolved in n-hexane.
- the sample was introduced into an autosampler 13 , and the supercritical chromatograph is actuated.
- Supercritical carbon dioxide and a modifier are respectively transported to a column 14 via a pump 11 and a liquid pump 12 .
- the chromatograph column 14 is sequentially connected to a diode array detector 15 and a pressure control unit 16 via connection parts 41 and 46 of the six-way valve to form a flow path A.
- nonpolar oil or fat components are washed off in the column 14 , and weakly polar components containing vitamin D are adsorbed to the stationary phase of the column 14 . Thereby, preliminary washing of the weakly polar components containing vitamin D is completed.
- connection parts 41 and 46 are disconnected, connection parts 41 and 42 are connected, and connection parts 45 and 46 are connected, thus forming a flow path B.
- This flow path sequentially includes the column 14 , a column 22 , the diode array detector 15 , and the pressure control unit 16 .
- the modifier whose flow rate has been increased, transports the weakly polar components from the column 14 to the column 22 . Further, the pressure control unit 16 discharges the supercritical carbon dioxide remaining in the system.
- connection parts 42 and 43 , and connection parts 44 and 45 of the six-way valve are respectively connected while the connection parts 41 and 42 , and the connection parts 45 and 46 of the six-way valve are respectively disconnected, and a polar mobile phase is supplied to the column 22 by a liquid pump 21 .
- a flow path C including two reverse phase liquid chromatography columns 22 and 23 connected in series is formed.
- the weakly polar components are allowed to flow from the column 22 to the column 23 via a pipe line, thus completing separation of vitamin D component in the column 23 .
- the column 23 can be directly connected to a mass spectrometric detector 24 at the end of the flow path C. Thereby, analysis and detection of respective components of vitamin D can be achieved.
- the second embodiment of the present invention provides a system that is applied to analysis and detection of highly lipophilic components, in particular, a system that is applied to automatic detection of highly lipophilic components, for example, vitamin D in an oil or fat, or a biological sample.
- a system that is applied to automatic detection of highly lipophilic components, for example, vitamin D in an oil or fat, or a biological sample.
- Such a system is used for performing the method of detecting highly lipophilic components, in particular, vitamin D in the first embodiment of the present invention.
- Such a system includes:
- a multidimensional chromatography system including a supercritical chromatography column and one or more reverse phase liquid chromatography columns, a nonpolar substance being eluted and removed in the supercritical chromatography column, and a weakly polar substance being adsorbed to a stationary phase of the supercritical chromatography column and further transported to the reverse phase liquid chromatography column;
- a liquid pump configured to transport a modifier to the supercritical chromatography column and transport a mobile phase to the one or more reverse phase liquid chromatography columns;
- the modifier used for the supercritical liquid chromatography is the same as the modifier described above.
- the modifier is one selected from alcohol, nitrile, and an aqueous solution of alcohol or nitrile, and is preferably methanol or a methanol aqueous solution. In some preferred embodiments of the present invention, an 80% or more, or 90% or more methanol aqueous solution can be used.
- the multi-way valve group connects or switches connection between the supercritical chromatography column and the one or more reverse phase liquid chromatography columns in the multidimensional chromatography system.
- the multi-way valve group of the present invention is preferably a six-way valve group or a ten-way valve group.
- the weakly polar substances adsorbed to the supercritical chromatography column are transported to the reverse phase liquid chromatography column by only the action of the modifier to remove the supercritical mobile phase flowing out of the supercritical chromatography column in the reverse phase liquid chromatography column.
- the weakly polar substance adsorbed to the supercritical chromatography column is transported to the reverse phase liquid chromatography column by the action of the modifier to remove the supercritical mobile phase flowing out of the supercritical chromatography column in the reverse phase liquid chromatography column. Further, the weakly polar substances separate into components in the reverse phase liquid chromatography column.
- the weakly polar substances adsorbed to the supercritical chromatography column are transported to the first chromatography column by only the action of the modifier to remove the supercritical mobile phase flowing out of the supercritical chromatography column in the first chromatography column.
- the weakly polar substances are transported to the second reverse phase liquid chromatography column to separate components.
- the stationary phase and the mobile phase used for such a supercritical chromatography column and reverse phase liquid chromatography column are each in the same range as those disclosed above.
- a reverse phase liquid chromatography column which performs separation of at least weakly polar substances is placed in an oven.
- such a system has a pretreatment column for separating protein components in a sample to be analyzed.
- a pretreatment column can be placed in, for example, the upstream of the supercritical chromatography column.
- Vitamin D 2 and vitamin D 3 purchased from the laboratory of Dr. Ehrenstorfer.
- Vitamin supplement (Baby Ddrops, lot number: 187759, liquid vitamin D 3 , 400 IU/drop, purchased from Ddrops Company).
- Methanol (LC-MS grade) and hexane (HPLC grade) (SFC grade of Thermo Fisher Scientific).
- Carbon dioxide (CO 2 , purity ⁇ 99.99%, Beijing, China).
- the UC system is constituted by a CBM-20A controller, an online DGU-20A degas chamber, an LC-30AD SF CO 2 pump, an LC-30 AD modifier pump, an SIL-30AC autosampler (equipped with a 5 ⁇ L sample loop), a CTO-20AC column oven, an SPD M20A diode array detector (equipped with a high-voltage battery), and one SFC-30A back-pressure regulator (BPR). Further, one high-pressure six-way valve for switching columns is placed in a column oven. For data collection and system control, Shimadzu Labsolution Ver. 5.8.5 was used.
- An SFC column (4.6 mm ⁇ 250 mm, 5 ⁇ m) includes an SFC mode used for preliminary separation, and contains three materials of UC-X silica, UC-X NH 2 , and UC-X (diol group).
- a short C18 column (VP-ODS, 4.6 mm ⁇ 50 mm, 5 ⁇ m), a long C18 column for separation of vitamin D (4.6 mm ⁇ 250 mm, 5 ⁇ m), and two reference columns composed of a diol group column and a C18 column (4.0 mm ⁇ 10 mm, 5 ⁇ m) for checking the retention time of vitamin D in a case of using methanols with different proportions for the mobile phase are used. All columns were purchased from Shimadzu-GL Sciences (Shanghai) Laboratory Supplies Co., Ltd.
- a standard stock solution of vitamin D was prepared in n-hexane such that D 3 was 1 mg/mL and D 2 was 1 mg/mL. All standard stock solutions are stored at ⁇ 30° C.
- a test standard solution is prepared by diluting a stock solution of vitamin D with n-hexane to be 10 to 200 ⁇ g/L.
- Baby Ddrops (about 10 ⁇ g/drop) was diluted with n-hexane.
- the final concentration of vitamin D 3 was about 100 ⁇ g/L.
- a droplet agent of vitamin AD was pushed out from a soft capsule, and diluted with n-hexane.
- the final concentration of vitamin D 3 was about 125 ⁇ g/L.
- the SFC and LC/MS include a high-pressure six-way valve which changes a position between 0 and 1. In one analysis, the valve changed twice, and there were three steps.
- a sample containing vitamin D was injected into a system, and a mixture of a supercritical carbon dioxide fluid and methanol was passed through the system.
- the vitamin D sample was passed through a normal phase column, whereby vitamin D and impurities were each retained in the column to be separated.
- the BPR provides a back-pressure of 15 MPa.
- two C18 columns for pretreatment and reverse phase separation were used, and washing was performed with methanol at a flow rate of 1 ml/min.
- the position of the valve was switched from the position 0 to the position 1 before vitamin D is eluted from the SFC column, and the operation of the CO 2 pump was stopped. Only methanol flowing at a flow rate of 0.5 mL/min remained in the mobile phase, and the back-pressure of the BPR was kept 15 MPa. Vitamin D and remaining supercritical CO 2 were allowed to flow from the SFC column to a pretreatment C18 column (length: 50 mm). Vitamin D was retained in the pretreatment C18 column, and the supercritical CO 2 fluid was eluted from the column and discharged. Meanwhile, a reverse phase separation C18 column (length: 250 mm) was washed with methanol still flowing at a flow rate of 1 mL/min.
- the valve was returned from the position 1 to the position 0 before vitamin D is eluted from the pretreatment C18 column, thus allowing vitamin D to flow from the pretreatment C18 column to the reverse phase separation C18 column with methanol at a flow rate of 1 mL/min.
- Vitamin D was separated in the reverse phase separation C18 column, and then detected by the MS/MS.
- Data collection was performed in a cationic electrospray ionization (ESI) mode as follows. The conditions are as follows.
- vitamin D The retention behavior of vitamin D was examined by using three supercritical fluid columns (NH 2 , diol, and silica) having different polar functional groups.
- the retention time of vitamin D increased with decrease in the content of methanol serving as a modifier in each column.
- the retention times of vitamin D 2 and D 3 are approximately the same.
- Vitamin D exhibited the longest retention time in a diol group column compared to NH 2 and silica columns. A longer retention time means that the vitamin D components do not dissolve or elute, and thus time required for washing and removing nonpolar oil or fat components in the SFC column is long.
- a diol group column was selected, and the flow rate of methanol serving as the modifier was set to 2% (relative to the flow rate of the supercritical CO 2 ). The column was used for washing an oily product or a lipid sample containing vitamin D.
- the results show that, as a whole, a case of using a high content of methanol as the modifier (90% and 100% methanol) while keeping the ratio of the flow rate of the modifier to the flow rate of the supercritical CO 2 low in the SFC process results in longer retention time of vitamin D in the SFC washing process, rapid elution of the vitamin D components from the SFC column even after supply of supercritical carbon dioxide is stopped, and thus ensures achievement of pretreatment with the C18 column.
- the retention behavior of the C18 column was examined with different contents of methanol.
- decrease in the content of methanol in the mobile phase results in increase in the retention time of vitamin D 3 ( FIG. 4 )
- the C18 column can still employ a high content of methanol solution as the modifier. That is, it is possible to use the same composition for the modifier in the SFC and the mobile phase used for the C18 column. That is, a high content of methanol not only allows vitamin D 3 to be rapidly eluted from the diol group column, but also ensures sufficient retention time of vitamin D 3 in the C18 column.
- both of the modifier in the SFC column and the mobile phase used for the C18 column can be a high content of methanol.
- the modifier in the SFC column and the modifier of the mobile phase in the C18 column were determined. Then, the switching time from the SFC column to the pretreatment C18 column was set to 8.5 minutes, and the switching time from the pretreatment C18 column to the reverse phase separation C18 column was set to 17.5 minutes.
- vitamin D 2 and D 3 were injected in the column switching system. As shown in FIG. 5 , vitamin D 2 and D 3 were eluted from all the three columns, and were respectively detected at the time point of 24.9 minutes and 25.5 minutes by the MS/MS. The two peaks of vitamin D 2 and D 3 were sharp and symmetry, resulting in complete separation. The solvent peak was detected at the time point of 20.0 minutes.
- a vitamin D supplement for infants, Baby Ddrops was directly analyzed by using the analysis system of the present invention.
- An oily sample was diluted with n-hexane, and then the diluted sample was injected into the analysis system.
- the detection method and the apparatus of the present invention can be used for analysis of highly lipophilic components, in particular, vitamin D components in the industrial production.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
- Patent Literature 1: CN 1144782 C
- Non Patent Literature 1: “Simultaneous determination of vitamins A, D3 and E in infant and adult formula nutritions by online two-dimensional liquid chromatography”, Zhang Yanhai, «chromatography», March, 2015
- Non Patent Literature 2: “Simultaneous determination of multiple vitamins in infant powdered formula by ultra-performance liquid chromatography/supercritical fluid chromatography-tandem mass spectrometry”, Quan Sisi, Guangdong Pharmaceutical University, thesis for master degree, 2017
-
- [1]. A method for rapidly analyzing and detecting vitamin D in a highly lipophilic component, in particular, an oil or fat or a biological sample, the method including:
- step S1 of preparing a sample to be analyzed;
- step S2 of separating vitamin D in the sample to be analyzed by using a multidimensional chromatography system; and
- step S3 of detecting the vitamin D separated in the step S2, in which
- in the step S2, the multidimensional chromatography system includes a supercritical chromatography part and a reverse phase liquid chromatography part which are sequentially connected;
- the reverse phase liquid chromatography part includes one or more reverse phase liquid chromatography columns;
- the supercritical chromatography part includes a supercritical mobile phase and a modifier; and
- the modifier is selected from alcohol, nitrile, and an aqueous solution of alcohol, or nitrile, and is preferably, methanol or an aqueous solution of methanol.
- [2]. The method according to [1], in which the supercritical chromatography part includes one supercritical chromatography column, and the reverse phase liquid chromatography part includes two reverse phase liquid chromatography columns.
- [3]. The method according to [1] or [2], in which a multi-way valve group connects chromatography columns in the multidimensional chromatography system.
- [4]. The method according to any one of [1] to [3], in which in the supercritical chromatography part,
- the stationary phase is selected from a silica gel modified with a polar group selected from a hydroxy group, an amino group, and a cyano group, and preferably, the modified silica gel is selected from a diol group silica gel; and
- the mobile phase is supercritical carbon dioxide.
- [5]. The method according to any one of [1] to [4], in which in the reverse phase liquid chromatography part,
- the stationary phase is selected from a silica gel modified with a hydrophobic group selected from an alkyl group, and preferably, the modified silica gel is a C18 silica gel; and
- the mobile phase is a polar organic solvent or an aqueous solution of the polar organic solvent.
- [6]. The method according to any one of [1] to [5], in which reverse phase liquid chromatography columns of the reverse phase liquid chromatography part are identical or different.
- [7]. The method according to any one of [1] to [6], in which in the step S2, a weakly polar substance adsorbed to the supercritical chromatography is transported to the reverse phase liquid chromatography part by only an action of the modifier, and a supercritical mobile phase flowing out of the supercritical chromatography part is removed in the reverse phase liquid chromatography part.
- [8]. The method according to any one of [1] to [7], in which the step S2 further includes:
- step S21 of separating a component of a sample to be analyzed by using supercritical chromatography and transporting a weakly polar substance to a reverse phase liquid chromatography part;
- step S22 of removing a supercritical mobile phase flowing out of the supercritical chromatography in the reverse phase liquid chromatography; and
- step S23 of introducing a mobile phase into the reverse phase liquid chromatography and separating a substance present in the reverse phase liquid chromatography to obtain a vitamin D component separated, in which
- transport of the weakly polar substance to the reverse phase liquid chromatography column in the step S21 may be performed at the same time as the step S22.
- [9]. The method according to any one of [1] to [7], in which the step S2 further includes:
- step S21′ of separating a component of a sample by using supercritical chromatography and transporting a weakly polar substance to a first reverse phase liquid chromatography column of the reverse phase liquid chromatography part;
- step S22′ of removing a supercritical mobile phase flowing out of the supercritical chromatography in the first reverse phase liquid chromatography column; and
- step S23′ of further introducing a mobile phase into the first reverse phase liquid chromatography column, and transporting a weakly polar substance present in the chromatography column to a second reverse phase liquid chromatography column to be separated in the second reverse phase liquid chromatography column, thus obtaining a vitamin D component, in which
- transport of the weakly polar substance to the first reverse phase liquid chromatography column in the step S21′ may be performed at the same time as the step S22′.
- [10]. The method according to any one of [1] to [9], the method including, before the step S2, a step of separating a protein component in a sample to be analyzed by using a pretreatment chromatography column, in which in the step S3, detection is performed by using a mass spectrometer.
- [1]. A method for rapidly analyzing and detecting vitamin D in a highly lipophilic component, in particular, an oil or fat or a biological sample, the method including:
-
- [11] An analysis system including:
- an autosampler;
- a multidimensional chromatography system including a supercritical chromatography column and one or more reverse phase liquid chromatography columns, a nonpolar substance being eluted and removed in the supercritical chromatography column, and a weakly polar substance being adsorbed to a stationary phase of the supercritical chromatography column and further transported to the one or more reverse phase liquid chromatography columns;
- a column oven in which a column is to be provided;
- a liquid pump configured to transport a modifier to the supercritical chromatography column and transport a mobile phase to the one or more reverse phase liquid chromatography columns; and
- a mass spectrometer.
- [12] The system according to [11], in which the modifier is selected from alcohol, nitrile, and an aqueous solution of alcohol or nitrile, and is preferably, methanol or an aqueous solution of methanol.
- [13] The system according to [11] or [12], in which a multi-way valve group connects or switches connection between the supercritical chromatography column and the one or more reverse phase liquid chromatography columns in the multidimensional chromatography system.
- [14] The system according to any one of [11] to [13], in which a weakly polar substance adsorbed to the supercritical chromatography column is transported to the reverse phase liquid chromatography column by only an action of the modifier to remove a supercritical mobile phase flowing out of the supercritical chromatography column in the reverse phase liquid chromatography column.
- [15] The system according to any one of [11] to [14], in which the multidimensional chromatography system includes one reverse phase liquid chromatography column; and a weakly polar substance adsorbed to the supercritical chromatography column is transported to the reverse phase liquid chromatography column by only an action of the modifier, a supercritical mobile phase flowing out of the supercritical chromatography column is removed in the reverse phase liquid chromatography column, and then a component of the weakly polar substance is separated by the reverse phase liquid chromatography column.
- [16] The system according to any one of [11] to [14], in which the multidimensional chromatography system includes two reverse phase liquid chromatography columns; and a weakly polar substance adsorbed to the supercritical chromatography column is transported to a first reverse phase liquid chromatography column by only an action of the modifier to remove a supercritical mobile phase flowing out of the supercritical chromatography column in the reverse phase liquid chromatography column,
- then the weakly polar substance is transported to a second reverse phase liquid chromatography column to separate a component.
- [17] The system according to any one of [11] to [16], in which in the supercritical chromatography column,
- the stationary phase is selected from a silica gel modified with a polar group selected from a hydroxy group, an amino group, and a cyano group, and preferably, the modified silica gel is a diol group silica gel; and
- the mobile phase is supercritical carbon dioxide.
- [18] The system according to any one of [11] to [17], in which in the reverse phase liquid chromatography column,
- the stationary phase is selected from a silica gel modified with a hydrophobic group selected from a hydrocarbon group, and preferably, the modified silica gel is a C18 silica gel; and
- the mobile phase is a polar organic solvent or an aqueous solution of the polar organic solvent.
- [19] The system according to any one of [11] to [18], in which at least the reverse phase liquid chromatography column configured to perform separation of the weakly polar substance is placed in a column oven.
- [20] The system according to any one of [11] to [19], in which the system has a pretreatment column configured to separate a protein component in a sample to be analyzed.
- [21] The system according to any one of [11] to [19], in which the system is used for automatically detecting a highly lipophilic component in an oil or fat or a biological sample.
- [22] The system according to [21], in which the highly lipophilic component is vitamin D.
- [11] An analysis system including:
TABLE 1 |
Level of linearity of vitamin D detection in |
column switching system |
Linear | |||||
Component | Formula | r2 | range (μg/L) | ||
Vitamin D2 | y = 1159.1x − 8199.7 | 0.9987 | 20~200 | ||
Vitamin D3 | y = 2792.5x − 15359 | 0.9991 | 20~200 | ||
<Analysis of Oily Droplet of Vitamin D3>
-
- 11 . . . CO2 Pump
- 12 . . . Methanol Liquid Pump
- 13 . . . Autosampler
- 14 . . . Supercritical Chromatography Column (Diol Group)
- 15 . . . Detector (Diode Array Detector)
- 16 . . . Pressure Control Unit (Back-Pressure Control Unit)
- 21 . . . Methanol Liquid Pump
- 22 . . . Reverse Phase Liquid Chromatography Column (C18)
- 23 . . . Reverse Phase Liquid Chromatography Column (C18)
- 24 . . . Mass spectrometric Detector
- 41-46 . . . Six-Way Valve Group
Claims (17)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810394669.1A CN110412139A (en) | 2018-04-27 | 2018-04-27 | A kind of analysis system |
CN201810394669.1 | 2018-04-27 | ||
PCT/JP2019/002587 WO2019207870A1 (en) | 2018-04-27 | 2019-01-25 | Analysis system |
Publications (2)
Publication Number | Publication Date |
---|---|
US20210239656A1 US20210239656A1 (en) | 2021-08-05 |
US11946911B2 true US11946911B2 (en) | 2024-04-02 |
Family
ID=68293816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/049,249 Active 2040-10-09 US11946911B2 (en) | 2018-04-27 | 2019-01-25 | Analysis system and method for rapidly detecting vitamin d in an oil or fat, or a biological sample |
Country Status (4)
Country | Link |
---|---|
US (1) | US11946911B2 (en) |
JP (1) | JP7092189B2 (en) |
CN (2) | CN110412139A (en) |
WO (1) | WO2019207870A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112881539A (en) * | 2019-11-29 | 2021-06-01 | 岛津企业管理(中国)有限公司 | Method for rapidly detecting benzopyrene |
CN113295810B (en) * | 2021-05-26 | 2023-03-24 | 天津海关动植物与食品检测中心 | Online analysis method for overlapped sample injection of chromatographic system |
CN118425391A (en) * | 2023-01-31 | 2024-08-02 | 岛津企业管理(中国)有限公司 | Detection system and chiral compound detection method |
CN118583990A (en) * | 2023-03-03 | 2024-09-03 | 岛津企业管理(中国)有限公司 | Method for detecting pyropheophytin a copper in grease sample |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS631968A (en) | 1986-06-20 | 1988-01-06 | Shimadzu Corp | Apparatus for analyzing vitamin |
US5492555A (en) * | 1994-06-09 | 1996-02-20 | Lovelace Biomedical & Environmental Research Institute, Inc. | Automated two-dimensional interface for capillary gas chromatography |
US5550166A (en) * | 1995-03-17 | 1996-08-27 | Ostlund; Richard E. | Pinitol and derivatives thereof for the treatment of metabolic disorders |
JPH08310809A (en) | 1995-05-17 | 1996-11-26 | Wako Pure Chem Ind Ltd | New modified silica gel |
EP1122250A1 (en) | 2000-02-02 | 2001-08-08 | Malaysian Palm Oil Board | A method of chromotagraphic isolation for vitamin E isomers |
CN1144782C (en) | 1998-06-23 | 2004-04-07 | 弗·哈夫曼-拉罗切有限公司 | Separation process for vitamin D3 |
US20120240666A1 (en) | 2011-03-23 | 2012-09-27 | Carl Sims | Valve and Splitting System for Multi-Dimensional Liquid Analysis |
US20140147878A1 (en) * | 2010-10-29 | 2014-05-29 | Cohesive Technologies Inc. | Lc-ms separation and detection of vitamin d metabolites |
US20140319057A1 (en) | 2012-05-15 | 2014-10-30 | Waters Technologies Corporation | Chromatographic materials for the separation of unsaturated molecules |
JP2015194363A (en) | 2014-03-31 | 2015-11-05 | 株式会社島津製作所 | Supercritical fluid chromatograph having normal phase and reverse phase and analytic method using the same |
JP2015215320A (en) | 2014-05-13 | 2015-12-03 | 株式会社島津製作所 | Simultaneous analytical method of sample containing compounds having different polarities |
JP2017512310A (en) | 2014-03-01 | 2017-05-18 | ウオーターズ・テクノロジーズ・コーポレイシヨン | Chromatographic material for separating unsaturated molecules |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY127954A (en) * | 1999-11-04 | 2007-01-31 | Malaysian Palm Oil Board | A method of chromatographic isolation for non-glyceride components |
-
2018
- 2018-04-27 CN CN201810394669.1A patent/CN110412139A/en not_active Withdrawn
-
2019
- 2019-01-25 CN CN201980042766.7A patent/CN112334766B/en active Active
- 2019-01-25 WO PCT/JP2019/002587 patent/WO2019207870A1/en active Application Filing
- 2019-01-25 JP JP2020516030A patent/JP7092189B2/en active Active
- 2019-01-25 US US17/049,249 patent/US11946911B2/en active Active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS631968A (en) | 1986-06-20 | 1988-01-06 | Shimadzu Corp | Apparatus for analyzing vitamin |
US5492555A (en) * | 1994-06-09 | 1996-02-20 | Lovelace Biomedical & Environmental Research Institute, Inc. | Automated two-dimensional interface for capillary gas chromatography |
US5550166A (en) * | 1995-03-17 | 1996-08-27 | Ostlund; Richard E. | Pinitol and derivatives thereof for the treatment of metabolic disorders |
JPH08310809A (en) | 1995-05-17 | 1996-11-26 | Wako Pure Chem Ind Ltd | New modified silica gel |
CN1144782C (en) | 1998-06-23 | 2004-04-07 | 弗·哈夫曼-拉罗切有限公司 | Separation process for vitamin D3 |
EP1122250A1 (en) | 2000-02-02 | 2001-08-08 | Malaysian Palm Oil Board | A method of chromotagraphic isolation for vitamin E isomers |
JP2001261671A (en) | 2000-02-02 | 2001-09-26 | Malaysian Palm Oil Board | Method of isolating vitamin e isomers by chromatography |
US20010044548A1 (en) | 2000-02-02 | 2001-11-22 | May Choo Yuen | Method for the chromatographic isolation of vitamin E isomers |
US20140147878A1 (en) * | 2010-10-29 | 2014-05-29 | Cohesive Technologies Inc. | Lc-ms separation and detection of vitamin d metabolites |
WO2012129076A1 (en) | 2011-03-23 | 2012-09-27 | Idex Health & Science Llc | Valve and splitting system for multi-dimensional liquid analysis |
US20120240666A1 (en) | 2011-03-23 | 2012-09-27 | Carl Sims | Valve and Splitting System for Multi-Dimensional Liquid Analysis |
JP2014514541A (en) | 2011-03-23 | 2014-06-19 | アイデックス ヘルス アンド サイエンス エルエルシー | Valves and splitting systems for multidimensional liquid analysis |
CN103930778A (en) | 2011-03-23 | 2014-07-16 | 明尼苏达大学评议会 | Valve and splitting system for multi-dimensional liquid analysis |
US20140319057A1 (en) | 2012-05-15 | 2014-10-30 | Waters Technologies Corporation | Chromatographic materials for the separation of unsaturated molecules |
CN104428045A (en) | 2012-05-15 | 2015-03-18 | 沃特世科技公司 | Chromatographic materials |
GB2521524A (en) | 2012-05-15 | 2015-06-24 | Waters Technologies Corp | Chromatographic materials |
WO2015134317A1 (en) | 2012-05-15 | 2015-09-11 | Waters Technologies Corporation | Chromotographic materials for the separation of unsaturated molecules |
CN106457066A (en) | 2012-05-15 | 2017-02-22 | 沃特世科技公司 | Chromatographic materials for the separation of unsaturated molecules |
JP2017512310A (en) | 2014-03-01 | 2017-05-18 | ウオーターズ・テクノロジーズ・コーポレイシヨン | Chromatographic material for separating unsaturated molecules |
JP2015194363A (en) | 2014-03-31 | 2015-11-05 | 株式会社島津製作所 | Supercritical fluid chromatograph having normal phase and reverse phase and analytic method using the same |
JP2015215320A (en) | 2014-05-13 | 2015-12-03 | 株式会社島津製作所 | Simultaneous analytical method of sample containing compounds having different polarities |
Non-Patent Citations (21)
Title |
---|
Chinese Office Action dated Sep. 1, 2023 in Application No. 201980042766.7. |
Communication dated Dec. 5, 2022 in Chinese Patent Application No. 201980042766.7. |
Communication dated Oct. 19, 2021 issued by the Japanese Patent Office in Application No. 2020- 516030. |
Decision of Rejection dated Mar. 31, 2023 issued for the corresponding Chinese Patent Application No. 201980042766.7. |
Francois et al., "Comprehensive supercritical fluid chromatography x reversed phase liquid chromatography for the analysis of the fatty acids in fish oil", Journal of Chromatography A, 2009, vol. 1216, pp. 4005-4012 (8 pages total). |
Francois et al., "Construction of a new interface for comprehensive supercritical fluid chromatography x reversed phase liquid chromatography (SFC x RPLC)", Journal of Separation Science, 2008, vol. 31, pp. 3473-3478 (6 pages total). |
Hamada et al., "Determination of vitamin D in oily drops using a column-switching system with an on-line clean-up by supercritical fluid chromatography", Talanta, 2018, vol. 190, pp. 9-14 (6 pages total). |
International Search Report dated Apr. 16, 2019 in International Application No. PCT/JP2019/002587. |
International Search Report dated May 7, 2019 in International Application No. PCT/JP2019/002588. |
Jenkinson et al., "Analysis of multiple vitamin D metabolites by ultra-performance supercritical fluid chromatography-tandem mass spectrometry (UPSFC-MS/MS)", Journal of Chromatography B, 2018, vol. 1087-1088, pp. 43-48 (6 pages total). |
Jia Yong-Juan et al., "Determination of theophylline in human serum by HPLC method with online SPE technology", Chinese Journal of Hospital Pharmacy, 2018, pp. 1-6 (14 pages total). |
Jumaah et al., "A rapid method for the separation of vitamin D and its metabolites by ultra-high performance supercritical fluid chromatography-mass spectrometry", Journal of Chromatography A, 2016, vol. 1440, pp. 191-200 (10 pages total). |
Koga, "Tips for improving separation", LC Technical Report, vol. 17, No. 1, Apr. 2015, General Incorporated Association Chemicals Evaluation and Research Institute, [retrieved from URL: http://www.cerij.or.jp/service/09_chromatography/technical_report/technical_report_17.pdf], pp. 1 to 4, (8 pages total). |
National Food Safety Standard Determination of Vitamin A, D, E in Food, 2016 (50 pages total). |
Office Action dated Apr. 5, 2022 in Japanese Application No. 2020-516030. |
Office Action dated May 7, 2022 issued by the Chinese Patent Office in Chinese Application No. 201980042766.7. |
Quan Sisi, "Simultaneous determination of multiple vitamins in infant formula by ultra-performance liquid chromatography/supercritical fluid chromatography-tandem mass spectrometry", Guangdong Pharmaceutical University, thesis for master degree, 2017 (137 pages total). |
Taguchi et al., "Simultaneous analysis for water-and fat-soluble vitamins by a novel single chromatography technique unifying supercritical fluid chromatography and liquid chromatography", Journal of Chromatography A, 2014, vol. 1362, pp. 270-277 (8 pages total). |
Written Opinion of the International Searching Authority dated Apr. 16, 2019 in International Application No. PCT/JP2019/002587. |
Written Opinion of the International Searching Authority dated May 7, 2019 in International Application No. PCT/JP2019/002588. |
Zhang Yanhai, "Simultaneous determination of vitamins A, D3 and E in infant formula and adult nutritions by online two-dimensional liquid chromatography", Chinese Journal of Chromatography, Mar. 2015, vol. 33, No. 3, pp. 291-297 (14 pages total). |
Also Published As
Publication number | Publication date |
---|---|
JP7092189B2 (en) | 2022-06-28 |
US20210239656A1 (en) | 2021-08-05 |
JPWO2019207870A1 (en) | 2021-04-22 |
CN112334766B (en) | 2023-10-03 |
CN110412139A (en) | 2019-11-05 |
WO2019207870A1 (en) | 2019-10-31 |
CN112334766A (en) | 2021-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019207871A1 (en) | Rapid detection method for vitamin d in oil/fat or biological sample | |
US11946911B2 (en) | Analysis system and method for rapidly detecting vitamin d in an oil or fat, or a biological sample | |
CN111896633B (en) | Analysis system | |
Luque-Garcıa et al. | Extraction of fat-soluble vitamins | |
Zhu et al. | Simultaneous determination of 13 aminoglycoside residues in foods of animal origin by liquid chromatography–electrospray ionization tandem mass spectrometry with two consecutive solid-phase extraction steps | |
Aydoğan | Nanoscale separations based on LC and CE for food analysis: A review | |
Pfeifer et al. | Determination of coumarins in the roots of Angelica dahurica by supercritical fluid chromatography | |
Blanco et al. | Simultaneous determination of fat-soluble vitamins and provitamins in dairy products by liquid chromatography with a narrow-bore column | |
WO2014085486A2 (en) | Methods and apparatus for the analysis of vitamin d metabolites | |
CN111948300B (en) | Method for simultaneously detecting multiple biological small molecules in biological sample and multidimensional liquid chromatographic analysis device used for method | |
Karrar et al. | Lipid-soluble vitamins from dairy products: Extraction, purification, and analytical techniques | |
Feng et al. | Determination of vitamin D3 in daily oily supplements by a two-dimensional supercritical fluid chromatography-liquid chromatography-mass spectrometry system | |
Teshima et al. | Simple determination of mycophenolic acid in human serum by column-switching high-performance liquid chromatography | |
Zhan et al. | Generic and rapid determination of low molecular weight organic chemical contaminants in protein powder by using ultra-performance liquid chromatography-tandem mass spectrometry | |
Hamada et al. | Determination of vitamin D in oily drops using a column-switching system with an on-line clean-up by supercritical fluid chromatography | |
Quesada et al. | Automated method for the determination of fat-soluble vitamins in serum | |
US10215765B2 (en) | Detection of vitamins A and E by tandem mass spectrometry | |
Gasparetto et al. | Development and validation of an HPLC–DAD method for analysis of the six major isoflavones in extracts from soybean processing | |
Kuklenyik et al. | Automated online and off-line solid-phase extraction methods for measuring isoflavones and lignans in urine | |
CN116529594A (en) | Testing a sampling unit fluidly coupled to a source | |
CN109655531B (en) | Method for simultaneously analyzing short-chain, medium-chain and long-chain acyl coenzyme A | |
CN102507772A (en) | Method for detecting antioxidative activity compound in mixture | |
Peng et al. | Determination of multi-residue pesticides in dairy products using single-step emulsification/demulsification clean-up strategy combined with low-pressure gas chromatography-tandem mass spectrometry | |
Berthelette et al. | Future-Proofing Validated Pharmacopeia Methods: A Case Study of Improving Throughput and Decreasing Operational Cost | |
Nollet | Determination of Water-and Fat-Soluble Vitamins in Infant Formulae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: SHIMADZU CORPORATION, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GUO, YANLI;HAMADA, NAOKI;HASHI, YUKI;SIGNING DATES FROM 20201211 TO 20201214;REEL/FRAME:055354/0693 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |